Article
 

HartungDanielPharmacyReportingDiscrepanciesBetween_TableS2.pdf

Pubblico Deposited

Contenuto scaricabile

Scarica il pdf
https://ir.library.oregonstate.edu/concern/articles/3x816p11m

Descriptions

Attribute NameValues
Creator
Abstract
  • BACKGROUND: Result summaries are now required to be reported in ClinicalTrials.gov for many 1 trials of drugs and devices. PURPOSE: To evaluate the consistency of reporting in trials that are both registered in the ClinicalTrials.gov results database and published in the literature. DATA SOURCES: ClinicalTrials.gov results database, matched publications identified through both ClinicalTrials.gov and a manual search of two electronic databases. STUDY SELECTION: 10% random sample of Phase III or IV trials with results in the ClinicalTrials.gov results database, completed before January 1, 2009, with two or more arms. DATA EXTRACTION: One reviewer extracted data from ClinicalTrials.gov results database and matching publications. A subsample was independently verified. Basic design features and results were compared between reporting sources and discrepancies were summarized. DATA SYNTHESIS: Of 110 reviewed trials with results, most were industry-sponsored, parallel design, drug studies. The most common inconsistency was the number of secondary outcome measures reported (80%). There were 16 trials (15%) that reported the primary outcome description inconsistently and 22 (20%) in which the primary outcome value was reported inconsistently. A total of 38 trials inconsistently reported the number of individuals with a serious adverse event (SAE), of which 33 (87%) reported more SAEs in ClinicalTrials.gov. Among the 84 trials that reported SAEs in ClinicalTrials.gov, 11 publications did not mention SAEs, 5 reported SAEs as zero or not occurring, and 21 reported a different number of SAEs. In 29 trials that reported deaths in ClinicalTrials.gov, 28% differed with the matched publication. LIMITATIONS: Small sample that includes earliest results posted to the database and therefore may reflect inexperience with the submission process. CONCLUSIONS: Reporting discrepancies between the ClinicalTrials.gov results database and matching publications are common. It is unclear which reporting source contains the most accurate account of trial results. ClinicalTrials.gov may provide a more comprehensive description of trial adverse events than the publication.
Dichiarazione dei diritti

Le relazioni

Parents:

Elementi

Thumbnail Titolo Data caricata Visibilità Azioni
file details HartungDanielPharmacyReportingDiscrepanciesBetween_TableS2.pdf 2017-07-26 Pubblico Scaricare